clinical trials of fixed duration treatments & novel targets in cll
Published 2 years ago • 180 plays • Length 7:55Download video MP4
Download video MP3
Similar videos
-
12:46
fixed duration treatment strategies in cll
-
2:41
fixed-duration vs continuous therapy in cll
-
17:23
updates in cll: key clinical trials in the frontline and r/r setting, pre-clinical data and mrd
-
4:07
overcoming the challenge of resistance to targeted therapies in cll
-
0:56
fixed-duration treatment strategies for frontline and relapsed cll
-
1:50
targeted therapy in cll in 2022 and in the future
-
6:43
key highlights in cll: clinical trial updates & the role of combination therapies and novel btkis
-
0:45
key trials in cll and designing a concept for treatment
-
4:02
living with chronic lymphocytic leukaemia (cll)
-
10:30
leukemia patient story: my 1st symptoms for cll | stephen's story (1/5) | the patient story
-
4:37
impacting cll management with lifestyle modification
-
4:31
the impact of high and low burden tp53 mutations on risk and treatment decision in cll
-
1:27
advances in btk and bcl2 inhibitors for cll
-
3:39
the role of novel therapies in r/r dlbcl
-
3:35
an insight into time-limited therapy in cll
-
4:44
7-year update on a phase ii trial of fixed-duration obinutuzumab, ibrutinib, and venetoclax for cll
-
2:14
ongoing trials investigating the efficacy of pirtobrutinib in cll
-
3:48
managing cll treatment in the future: targeted therapies and early intervention
-
1:29
the importance of treatment sequencing in cll
-
1:36
selecting the best treatment option in cll
-
2:22
improve study: mrd assessment as an endpoint to define treatment length and intensity in cll
-
5:03
understanding patient perspectives in cll treatment